Localised prostate prostate cancer refers to prostate cancer that has spread to areas outside the prostate gland, but remains in the prostate region, that is in the prostate gland and the seminal vesicles. As with all treatments choosing a treatment for localised prostate cancer, or cancer that is described as T1 or T2, depends on […]
Treatments Options Read More »
Tumour factors There are seven tumour factors, which dictate the best type of treatment for an individual cancer. The clinical stage, the prostate specific antigen (PSA) level, the Gleason score, the position of the cancer, the extent of the cancer and the likelihood of disease penetrating the capsule are all factors which influence the choice
Focal therapy for selective patients with prostate cancer is a relatively new treatment for a select group of patients for the treatment of localised prostate cancer. The treatment is recommended for patients with localised prostate cancer stage T1 and T2 who are not candidates for prostatectomy because of their age, their general state of being
Dr Stricker introduced the UroLift procedure for benign enlargement of the prostate at St Vincent’s Hospital. The first procedures were performed in April 2015. All patients were treated as day patients. The UroLift involves placing, at the time of cystoscopy, some needle placements to stretch the prostate away from the urethra. This imporves the flow
The UroLift Procedure Read More »
You can use the following American Urological Association (AUA) BPH Symptom Score Index to evaluate your enlarged prostate symptoms. Simply click the most accurate answer for each question. Your total score is automatically calculated, and you can use it to help determine the severity of your symptoms. Scoring Key: 0 Indicates not at all 1
BPH Symptom Score Questionnaire Read More »
Prof Stricker has introduced a new procedure for benign enlargement of the prostate to enable improvement in urinary function without affecting sexual function. The first case was performed at St Vincent’s in April 2015 and all patients were treated as day patients. The treatment involves placing, at the time of cystoscopy, some needle placements to
The UroLift Procedure Read More »
Benign prostatic enlargement is the non-cancerous enlargement of the prostate. It refers to benign prostatic hyperplasia (increase in the number of cells) or hypertrophy (increase in cell size). Benign prostatic enlargement is the most common prostate disease in men. Typically, the prostate grows to the size of a walnut, but may begin to grow again
Benign Prostatic Enlargement Read More »
All treatments aimed at eradicating localised prostate cancer carry a risk of impotence and may include erection problems, ejaculation disturbance or loss of libido or interest. However, sexual recovery is part of your journey to good health. The therapy for erection problems is initially medications such as Sildenafil (Viagra), Vardenafil (Cialis) or Tardanefil (Levitra). If
Active surveillance involves the careful monitoring of prostate cancer progression in patients with less aggressive tumours. An increasing proportion of patients with Gleason 6 cancers, particularly in the older age group, are having their tumours monitored. Monitoring involves four-monthly prostate specific antigen (PSA) testing, a repeat biopsy every 12 to18 months and then ongoing monitoring
Active Surveillance Read More »
HDR High dose rate (HDR) brachytherapy involves the placement of wires into the prostate to deliver high doses of radiation directly into the prostate. Three treatments are given over a 36-hour period and are intended for patients with advanced prostate cancer. By delivering a higher dose it is more likely to cure more aggressive cancers
Radiotherapy is an important management option for patients with localised prostate cancer. Radiotherapy uses targeted x-rays to destroy cancer cells with radiation and can cure cancer in many sites of the body. For low risk cancers the results are similar to those of surgery. However, the relapse rate appears to be higher if the cancer
Robot assisted laparoscopic prostatectomy is performed in less than two hours, there is minimal blood loss and the procedure is done through tiny incisions leading to a quicker recovery. Many patients are up and walking the same day and home within two days. The aim with this surgery is to achieve complete removal of the
The aim of the surgery is to cure the cancer and reduce the risk of incontinency and impotence. Having performed over 4,000 open surgery cases to date, the most in the Southern Hemisphere, I have been able to refine this technique to ensure exceptional outcomes in terms of cure, continency and minimal complications. A nerve sparing technique,
There are many treatment options for localised or locally advanced prostate cancer making it very difficult for patients to choose. Newly diagnosed patients must consider a myriad of factors including the risk of potential side effects, recommendations from physicians, family and friends, economic circumstances, prior medical care experiences, emotional feelings about a cancer diagnosis as
Choosing Treatment Read More »
